Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn's disease

Sumeet S. Mitter, Ariss Derhovanessian, Joseph D. Hillman, Daniel Z. Uslan

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Background. A 50-year-old man presented with a 2-3month history of left lower quadrant abdominal pain, right periorbital headache, blurry vision, tinnitus, polydipsia, right elbow pain, and a 32kg weight loss over the past year. He had a 34-year history of complicated Crohn's disease that was notable for surgical stricture repair and partial colectomy for bowel perforation. The patient was receiving mesalazine and 6-mercaptopurine and, 2 months before admission, had stopped a 4-month therapy course with the biologic agent adalimumab for treatment of Crohn's disease.Investigations. Physical examination, brain and elbow MRI scans, chest CT scan, routine blood analyses, assessment of coccidioidomycosis antibody levels, immunodiffusion and complement fixation studies in serum and cerebrospinal fluid, full-body technetium-99m nuclear bone scan, hematoxylin and eosin staining of resected tissue specimens.Diagnosis. Disseminated coccidioidomycosis with meningeal, bone, soft tissue and pulmonary involvement.Management. The patient underwent treatment with amphotericin B liposomal complex and oral fluconazole and right elbow surgical debridement and irrigation. All immunosuppressive therapy was stopped.

Original languageEnglish
Pages (from-to)231-235
Number of pages5
JournalNature Reviews Gastroenterology and Hepatology
Issue number4
StatePublished - Apr 2010
Externally publishedYes


Dive into the research topics of 'Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn's disease'. Together they form a unique fingerprint.

Cite this